Literature DB >> 22408171

Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets.

Cristina Alarcon1, C Bruce Verchere, Christopher J Rhodes.   

Abstract

Dysfunctional islet amyloid polypeptide (IAPP) biosynthesis and/or processing are thought contribute to formation of islet amyloid in type 2 diabetes. However, it is unclear how normal pro-IAPP biosynthesis and processing are regulated to be able to define such dysfunction. Here, it was found that acute exposure to high glucose concentrations coordinately regulated the biosynthesis of pro-IAPP, proinsulin, and its proprotein convertase PC1/3 in normal isolated rat islets, without affecting their respective mRNA levels. Pro-7B2 biosynthesis, like that of pro-PC2, did not appreciably change, but this was likely due to a much higher expression in pancreatic α-cells masking glucose regulation of their biosynthesis in β-cells. Biosynthesis of pro-SAAS, the putative PC1/3 chaperone, was unaffected by glucose, consistent with its scarce expression in β-cells. We conclude that translational control of pro-IAPP biosynthesis, in parallel to the pro-PC1/3, pro-PC2, and pro-7B2 proprotein-processing endopeptidases/chaperones, is the predominate mechanism to produce IAPP in islet β-cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22408171      PMCID: PMC3339648          DOI: 10.1210/en.2011-2019

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

1.  Insulin secretory granule biogenesis. Co-ordinate regulation of the biosynthesis of the majority of constituent proteins.

Authors:  P C Guest; E M Bailyes; N G Rutherford; J C Hutton
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

Review 2.  Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits.

Authors:  M Nishi; T Sanke; S Nagamatsu; G I Bell; D F Steiner
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

3.  Functional characterization of ProSAAS: similarities and differences with 7B2.

Authors:  Yolanda Fortenberry; Jae-Ryoung Hwang; Ekaterina V Apletalina; Iris Lindberg
Journal:  J Biol Chem       Date:  2001-11-21       Impact factor: 5.157

4.  The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation.

Authors:  Daniel J Morgan; Suwen Wei; Ivone Gomes; Traci Czyzyk; Nino Mzhavia; Hui Pan; Lakshmi A Devi; Lloyd D Fricker; John E Pintar
Journal:  J Neurochem       Date:  2010-03-26       Impact factor: 5.372

5.  The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited.

Authors:  L Orci
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

6.  Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases.

Authors:  H W Davidson; C J Rhodes; J C Hutton
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

7.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

Authors:  G J Cooper; A C Willis; A Clark; R C Turner; R B Sim; K B Reid
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Role of beta-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptide.

Authors:  Lucy Marzban; Genny Trigo-Gonzalez; Xiaorong Zhu; Christopher J Rhodes; Philippe A Halban; Donald F Steiner; C Bruce Verchere
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

9.  Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.

Authors:  Alexandra E Butler; Jennifer Jang; Tatyana Gurlo; Maynard D Carty; Walter C Soeller; Peter C Butler
Journal:  Diabetes       Date:  2004-06       Impact factor: 9.461

Review 10.  Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes?

Authors:  D F Steiner; S Ohagi; S Nagamatsu; G I Bell; M Nishi
Journal:  Diabetes       Date:  1991-03       Impact factor: 9.461

View more
  13 in total

1.  Amylin deposition in the brain: A second amyloid in Alzheimer disease?

Authors:  Kaleena Jackson; Gustavo A Barisone; Elva Diaz; Lee-way Jin; Charles DeCarli; Florin Despa
Journal:  Ann Neurol       Date:  2013-07-12       Impact factor: 10.422

2.  Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide.

Authors:  Jaques A Courtade; Evan Y Wang; Paul Yen; Derek L Dai; Galina Soukhatcheva; Paul C Orban; C Bruce Verchere
Journal:  Diabetologia       Date:  2016-12-20       Impact factor: 10.122

3.  Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.

Authors:  Juan R Peinado; Furqan Sami; Nina Rajpurohit; Iris Lindberg
Journal:  FEBS Lett       Date:  2013-09-13       Impact factor: 4.124

4.  The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity.

Authors:  Timothy S Jarvela; Hoa A Lam; Michael Helwig; Nikolai Lorenzen; Daniel E Otzen; Pamela J McLean; Nigel T Maidment; Iris Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-25       Impact factor: 11.205

5.  Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic β-cells.

Authors:  Diti Chatterjee Bhowmick; Aleksandar Jeremic
Journal:  J Biol Chem       Date:  2018-07-16       Impact factor: 5.157

6.  Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2.

Authors:  Gu Jing; Clara Westwell-Roper; Junqin Chen; Guanlan Xu; C Bruce Verchere; Anath Shalev
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

7.  FoxA2 and RNA Pol II mediate human islet amyloid polypeptide turnover in ER-stressed pancreatic β-cells.

Authors:  Diti Chatterjee Bhowmick; Lydia Burnett; Zhanar Kudaibergenova; Aleksandar M Jeremic
Journal:  Biochem J       Date:  2021-03-26       Impact factor: 3.857

8.  Npas4 is a novel activity-regulated cytoprotective factor in pancreatic β-cells.

Authors:  Paul V Sabatini; Nicole A J Krentz; Bader Zarrouki; Clara Y Westwell-Roper; Cuilan Nian; Ryan A Uy; A M James Shapiro; Vincent Poitout; Francis C Lynn
Journal:  Diabetes       Date:  2013-05-08       Impact factor: 9.461

Review 9.  The dynamic plasticity of insulin production in β-cells.

Authors:  Brandon B Boland; Christopher J Rhodes; Joseph S Grimsby
Journal:  Mol Metab       Date:  2017-05-04       Impact factor: 7.422

Review 10.  The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.

Authors:  Steven E Kahn; Yi-Chun Chen; Nathalie Esser; Austin J Taylor; Daniël H van Raalte; Sakeneh Zraika; C Bruce Verchere
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 25.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.